ABSTRACT
This study assessed the
effectiveness of smoking cessation support among patients with chronic
respiratory conditions in Birnin Kudu, Jigawa State, Nigeria. Smoking remains a
major public health concern globally and is a leading cause of preventable
diseases, particularly chronic respiratory conditions such as chronic
obstructive pulmonary disease (COPD), asthma, and chronic bronchitis. Despite
the known health risks, many patients continue to smoke due to nicotine
dependence, limited access to cessation services, and socio-cultural factors.A
descriptive cross-sectional survey design was adopted for the study. Data were
collected from a sample of 100 respondents selected from patients attending the
General Hospital Birnin Kudu. Structured questionnaires and interviews were
used as primary data collection tools, while secondary data were obtained from
hospital records and relevant literature. The data were analyzed using
descriptive and inferential statistical methods. The findings revealed that
although awareness of smoking cessation services was moderate among
respondents, the availability and utilization of comprehensive cessation
support were limited. Counseling was the most common form of intervention,
while access to pharmacological therapies such as nicotine replacement therapy
was minimal. The study also found that follow-up support was inconsistent,
contributing to high relapse rates among patients. Major barriers to smoking
cessation included nicotine addiction, lack of awareness, limited access to
medications, socio-cultural influences, and inadequate healthcare
infrastructure. The study concluded that smoking cessation support services in
Birnin Kudu are insufficient and not fully effective due to gaps in service
delivery, accessibility, and follow-up mechanisms. It recommended the
integration of structured smoking cessation programs into routine healthcare
services, increased availability of pharmacological support, improved training
for healthcare providers, and enhanced public awareness campaigns.
Overall, strengthening smoking cessation
interventions is essential for improving health outcomes among patients with
chronic respiratory conditions and reducing the burden of tobacco-related
diseases in Nigeria.
TABLE OF CONTENTS
Title
Page
Certification
Dedication
Acknowledgements
Abstract
Table of Contents
CHAPTER
ONE: INTRODUCTION
1.1 Background to the Study
1.2 Statement of the Problem
1.3 Aim and Objectives of the Study
1.4 Significance of the Study
1.5 Scope of the Study
1.6 Operational Definition of Terms
CHAPTER
TWO: LITERATURE REVIEW
2.1 Introduction
2.2 Conceptual Review
2.2.1 Smoking and Its Health Implications
2.2.2 Chronic Respiratory Conditions
2.2.3 Smoking Cessation Support
2.2.4 Effectiveness of Smoking Cessation Support
2.2.5 Barriers to Smoking Cessation
2.3 Theoretical Review
2.3.1 Health Belief Model (HBM)
2.3.2 Social Cognitive Theory (SCT)
2.3.3 Transtheoretical Model (Stages of Change)
2.4 Empirical Review
CHAPTER
THREE: RESEARCH METHODOLOGY
3.1 Introduction
3.2 Research Design
3.3 Study Area
3.4 Population of the Study
3.5 Sample Size and Sampling Technique
3.6 Research Instruments
3.7 Method of Data Collection
3.8 Validity and Reliability of Instrument
3.9 Method of Data Analysis
3.10 Ethical Considerations
CHAPTER
FOUR: RESULTS AND DISCUSSION
4.1 Introduction
4.2 Socio-Demographic Characteristics of Respondents
4.3 Smoking History of Respondents
4.4 Awareness and Availability of Smoking Cessation Support
4.5 Utilization of Smoking Cessation Support
4.6 Discussion of Findings
CHAPTER
FIVE: SUMMARY, CONCLUSION, AND RECOMMENDATIONS
5.1 Introduction
5.2 Summary
5.3 Recommendations
5.4 Conclusion
References
Appendices
CHAPTER ONE
INTRODUCTION
1.1 Background to the Study
Smoking
remains one of the most significant public health challenges globally,
representing a major cause of preventable illness and premature death. The
harmful effects of smoking have been well documented over the past decades,
with tobacco consumption being linked to more than 25 different diseases,
including chronic respiratory disorders, cardiovascular diseases, and several
forms of cancer (World Health Organization [WHO], 2021). Tobacco use affects nearly
every organ in the body, contributing to the progressive decline of pulmonary
function, which in turn increases the risk of chronic obstructive pulmonary
disease (COPD), emphysema, chronic bronchitis, and lung cancer (Centers for
Disease Control and Prevention [CDC], 2020).
Globally,
tobacco-related diseases claim over 8
million lives annually, and an alarming 80% of these deaths occur in low- and middle-income countries
where healthcare systems are already burdened by limited resources and
competing health priorities (WHO, 2021). The socioeconomic impact of smoking is
equally profound, resulting in substantial healthcare costs, productivity
losses, and reduced quality of life for individuals and their families. Tobacco
use not only affects smokers but also exposes non-smokers to second-hand smoke,
which is equally harmful and accounts for over 1.2 million deaths annually worldwide (Global Burden of Disease
Study, 2020).
In
Nigeria, smoking prevalence is
gradually increasing, particularly among young adults and urban populations.
Though national surveys indicate a relatively lower prevalence rate compared to
some developed countries, the trend is worrisome due to increasing exposure to
cigarettes, shisha, and other tobacco products (Adewuyi et al., 2020). The Nigerian Demographic and Health Survey (NDHS,
2018) reported that approximately 10%
of adult males and 1% of adult females currently use tobacco products,
with urban areas showing higher prevalence rates due to lifestyle influences
and peer pressure. The lack of strong regulatory frameworks and inadequate
enforcement of tobacco control policies contribute to the continued
accessibility and promotion of tobacco use among the population (Ekanem et al., 2019).
Birnin
Kudu, a semi-urban area in Jigawa State,
reflects this growing public health concern. While the region has made progress
in healthcare delivery, challenges remain in addressing lifestyle-related risk
factors such as smoking. Many individuals with chronic respiratory conditions
in Birnin Kudu experience limited access to smoking cessation support,
counseling, or pharmacological interventions. The healthcare facilities in the
area, including the General Hospital and Primary Health Centres, provide basic
respiratory care; however, structured smoking cessation programs are either
unavailable or underutilized. Patients diagnosed with chronic respiratory diseases (CRDs) such as asthma, chronic
bronchitis, and COPD often continue smoking, which worsens disease progression
and complicates treatment outcomes (Oluwole et
al., 2020).
Smoking
cessation—the process of quitting smoking and maintaining long-term
abstinence—is widely recognized as the most effective measure for improving
respiratory health and preventing further disease complications. According to
the U.S. Department of Health and Human
Services (2020), quitting smoking has immediate and long-term health
benefits, including improved lung function, reduced inflammation, and enhanced
immune response. Moreover, for individuals with established chronic respiratory
diseases, cessation helps slow disease progression, reduce hospitalization
rates, and improve overall quality of life (Fiore et al., 2018).
Effective
smoking cessation strategies typically combine behavioral counseling, pharmacotherapy
(such as nicotine replacement therapy, bupropion, or varenicline), and public health interventions like
anti-smoking campaigns and community education. In developed nations, these
strategies have been successfully implemented within healthcare systems, yielding
significant reductions in smoking prevalence. However, in Nigeria and other
developing countries, the availability and accessibility of such evidence-based
cessation programs remain limited (Onigbogi et
al., 2021).
Furthermore,
socio-cultural beliefs, lack of awareness, financial barriers, and inadequate
health system capacity hinder effective smoking cessation among patients. In
semi-urban areas like Birnin Kudu, stigma and misconceptions about smoking and
addiction often discourage individuals from seeking help. Health workers may
also lack adequate training in cessation counseling, which limits their ability
to deliver effective interventions. Additionally, there is insufficient data on
the success rates of existing cessation programs in the region, making it
difficult for policymakers and healthcare planners to develop targeted
interventions.
Given
these challenges, evaluating the effectiveness
of smoking cessation support for patients with chronic respiratory conditions in Birnin Kudu is both timely and
necessary. Such evaluation provides critical insights into the availability,
accessibility, and outcomes of existing cessation services. It also helps
identify gaps in implementation and areas requiring improvement, such as
patient education, behavioral support, and policy enforcement.
This
study, therefore, seeks to assess the level of support provided to patients
with chronic respiratory conditions who are attempting to quit smoking in
Birnin Kudu. It aims to explore the structure and quality of smoking cessation
interventions, patients’ awareness and attitudes towards quitting, and the
barriers affecting service utilization. The findings are expected to contribute
to the growing body of evidence on tobacco control in Nigeria and inform
policymakers, healthcare providers, and public health stakeholders in
developing more effective, locally adapted cessation programs.
Ultimately,
reducing smoking prevalence among individuals with chronic respiratory
conditions not only improves individual health outcomes but also contributes to
the attainment of global health goals, including the Sustainable Development Goal (SDG) 3, which aims to ensure healthy
lives and promote well-being for all at all ages. Addressing smoking behavior
in this population is a crucial step toward reducing preventable morbidity and
mortality and strengthening the overall healthcare response to chronic
respiratory diseases in Nigeria.
1.2 Statement of
the Problem
Globally,
the dangers of tobacco smoking and its association with numerous chronic
diseases, particularly respiratory conditions, are well established. Despite
the increasing awareness and global public health campaigns against smoking,
tobacco use continues to pose a major threat to human health. The World Health
Organization (WHO, 2021) estimates that smoking is responsible for over eight
million deaths annually, with a large percentage occurring in low- and
middle-income countries like Nigeria, where healthcare systems are already
overburdened and under-resourced. Smoking remains a critical contributor to the
development and progression of chronic respiratory diseases such as chronic
obstructive pulmonary disease (COPD), lung cancer, asthma, and chronic
bronchitis (CDC, 2020).
In
Nigeria, the burden of smoking-related illnesses has been rising steadily due
to changing lifestyles, increased tobacco marketing, and limited enforcement of
tobacco control laws (Ekanem et al.,
2019). Despite the ratification of the WHO Framework Convention on Tobacco
Control (FCTC) and the implementation of the National Tobacco Control Act of
2015, the availability and utilization of smoking cessation services in many
parts of the country remain grossly inadequate. Healthcare facilities often
focus on treating the symptoms of chronic respiratory diseases without
incorporating structured smoking cessation interventions into routine clinical
care. Consequently, many patients continue to smoke even after diagnosis,
worsening their conditions and increasing the risk of complications and
premature death (Onigbogi et al.,
2021).
Birnin
Kudu, a semi-urban area in Jigawa State, presents a typical case of this public
health gap. Anecdotal reports and preliminary observations suggest that smoking
remains relatively common among adults, including those diagnosed with chronic
respiratory illnesses. Despite the existence of public health campaigns and
general awareness of the dangers of smoking, actual behavioral change among
patients is minimal.
1.3 Aim and
Objectives of the Study
Aim
The
major aim of this study is to assess the effectiveness of smoking cessation
support for patients with chronic respiratory conditions in Birnin Kudu. The research seeks to determine how
well existing interventions—both clinical and community-based—help individuals
with chronic respiratory diseases quit smoking and sustain abstinence,
ultimately improving their health outcomes and quality of life.
Objectives
To
achieve this overarching aim, the study will pursue the following specific
objectives:
1. To identify the types of
smoking cessation support services available to patients with chronic
respiratory conditions in Birnin Kudu.
This objective seeks
to document and describe the range of cessation support mechanisms currently in
place within health facilities and the broader community. It includes
hospital-based counseling programs, pharmacological aids such as nicotine
replacement therapy, educational campaigns, and community outreach programs.
Understanding the types of services available is crucial for evaluating whether
patients are being provided with comprehensive, evidence-based interventions as
recommended by international guidelines (WHO, 2021).
2. To assess the level of
utilization of smoking cessation support services among patients with chronic
respiratory conditions in Birnin Kudu.
This objective
focuses on measuring how often and to what extent patients use these services.
Even when cessation support services exist, low levels of awareness, social
stigma, cultural factors, or financial constraints may hinder patients from
accessing them. By analyzing patterns of utilization, this study will reveal
barriers that limit participation and sustained engagement in smoking cessation
programs.
3. To evaluate the perceived
effectiveness of smoking cessation support in improving patient outcomes in
Birnin Kudu.
Beyond availability
and utilization, the study will investigate whether cessation interventions are
achieving their intended results. This includes examining patient-reported
outcomes such as reduced smoking frequency, improved respiratory function,
fewer hospital visits, and enhanced overall well-being. The findings will help
determine whether current strategies are effective, partially effective, or
require improvement, thereby providing data-driven insights for policymakers and
healthcare administrators.
1.4 Significance of the Objectives
The
formulation of these objectives is guided by the need to bridge the knowledge
gap regarding the effectiveness of smoking cessation programs in
resource-limited settings like Birnin Kudu. While global research highlights
the benefits of structured cessation support, there is limited localized data
on how these interventions perform in rural and semi-urban Nigerian contexts.
By focusing on the availability, utilization, and effectiveness of cessation
services, this study aims to provide comprehensive evidence that can guide
improvements in clinical practice and public health policy.
Ultimately,
the outcomes of this research will contribute to:
·
Enhancing patient-centered care for individuals
with chronic respiratory diseases;
·
Informing local health authorities on the need
for integrating structured smoking cessation support into routine medical
services; and
·
Strengthening national efforts toward tobacco
control and prevention of smoking-related morbidity and mortality
1.5 Scope of the
Study
This
study is specifically focused on assessing the effectiveness of smoking cessation
support among patients with chronic respiratory conditions in Birnin Kudu,
Jigawa State, Nigeria. The scope is deliberately restricted to individuals who
have been clinically
diagnosed with chronic respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), asthma, chronic bronchitis,
and other related pulmonary disorders. These patients represent a high-risk group for smoking-related
complications, making them a suitable population for this investigation.
The
study will examine the types of smoking cessation services that are currently
available within the healthcare system of Birnin Kudu, particularly in hospitals,
primary health centers, and any community-based programs that provide
assistance for smoking cessation. It will also focus on how frequently these
services are utilized by patients, the level of patient
awareness and participation, and the perceived effectiveness of these
interventions in promoting smoking abstinence and improving overall health
outcomes.
Furthermore,
the study will analyze the barriers and challenges faced by patients in accessing or
maintaining smoking cessation efforts. These may include socioeconomic
constraints, lack of professional counseling, limited availability of cessation
drugs, cultural attitudes toward smoking, or weak institutional support
systems. Understanding these limitations is critical to recommending strategies
that can improve the success of cessation interventions in similar low-resource
settings.
However,
the study will not extend to the general population or
community-wide prevalence of smoking in Birnin Kudu. It will
strictly focus on hospital-based and patient-specific data related to
individuals already diagnosed with chronic respiratory diseases. By narrowing
its focus, the research aims to generate more accurate, relevant, and
actionable insights regarding clinical and behavioral support for smoking
cessation among patients whose health conditions are directly affected by
tobacco use.
The
geographical scope is confined to Birnin Kudu Local Government Area,
which serves as the primary research setting due to its accessible health
facilities and representative patient population. The study findings, however,
may have broader implications for other localities in Jigawa State and Nigeria
as a whole, where similar health system characteristics and patient challenges
exist.
In
terms of time frame, the study will consider data and patient experiences
within a defined recent period (for example, the past 12 months), allowing for
the evaluation of current and ongoing cessation efforts. This approach ensures
that the findings are both timely and reflective of contemporary health service delivery within the study area.
1.6 Operational
Definition of Terms
For
clarity and precision, the following key terms are defined as they are used within
the context of this study:
Smoking Cessation Support
This
refers to all structured interventions, programs, and strategies designed to
help individuals stop smoking. These include behavioral counseling, pharmacological interventions
(such as nicotine replacement therapy and other cessation medications), public health campaigns, and educational or motivational programs
organized within healthcare facilities or the community. Smoking cessation
support aims to assist patients in overcoming nicotine dependence, preventing
relapse, and improving long-term health outcomes.
Chronic Respiratory Conditions
These
are long-term
diseases that affect the lungs and airways, often resulting in breathing difficulties, chronic coughing, and
reduced lung function. In this study, the term encompasses conditions such as Chronic Obstructive
Pulmonary Disease (COPD),
asthma, chronic bronchitis, and in some cases, lung cancer
related to prolonged tobacco use. Such conditions are often progressive,
requiring ongoing medical management and lifestyle changes, including smoking
cessation, to prevent further deterioration.
Effectiveness
In
this context, effectiveness refers to the degree to which smoking cessation support
achieves its intended outcomes. This includes measurable improvements such as a reduction in cigarette
consumption, complete abstinence from
smoking, improvement in respiratory
health indicators, and
better
quality of life among patients. Effectiveness also encompasses
patient satisfaction with the services provided and the sustainability of their
cessation outcomes over time.
Patients
For
the purpose of this study, patients refer to
individuals
who have been medically diagnosed with chronic respiratory conditions
and are receiving care, treatment, or follow-up within healthcare facilities in
Birnin Kudu
Local Government Area.
These patients may be in outpatient or inpatient care and must have a known
history of tobacco use or exposure. They constitute the study population from
whom primary data will be collected through questionnaires, interviews, or
clinical records.
Login To Comment